Latest Insider Transactions at Schwab Charles Corp (SCHW)
This section provides a real-time view of insider transactions for Schwab Charles Corp (SCHW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SCHWAB CHARLES CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SCHWAB CHARLES CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2025
|
Charles A. Ruffel Director |
SELL
Bona fide gift
|
Direct |
8,372
-46.13%
|
-
|
|
Nov 13
2025
|
Paula A Sneed Director |
SELL
Bona fide gift
|
Indirect |
8,680
-8.22%
|
-
|
|
Nov 12
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Bona fide gift
|
Direct |
1,032
-1.75%
|
-
|
|
Nov 12
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
3,072
-20.49%
|
$301,056
$98.0 P/Share
|
|
Nov 12
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
3,072
+6.62%
|
$141,312
$46.39 P/Share
|
|
Nov 12
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
52,500
-0.09%
|
-
|
|
Nov 10
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Bona fide gift
|
Indirect |
298
-0.02%
|
-
|
|
Nov 10
2025
|
Walter W Bettinger Co-Chairman |
SELL
Bona fide gift
|
Indirect |
61,388
-10.39%
|
-
|
|
Nov 10
2025
|
Paul V Woolway MD, Chief Banking Officer |
BUY
Bona fide gift
|
Indirect |
796
+20.58%
|
-
|
|
Nov 10
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Bona fide gift
|
Indirect |
1,089
-3.52%
|
-
|
|
Nov 07
2025
|
Jonathan M. Craig MD, Head of Investor Services |
SELL
Open market or private sale
|
Indirect |
35,188
-100.0%
|
$3,342,860
$95.35 P/Share
|
|
Nov 07
2025
|
Jonathan M. Craig MD, Head of Investor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
35,188
+100.0%
|
$1,442,708
$41.98 P/Share
|
|
Oct 29
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
44,750
-0.08%
|
$4,206,500
$94.52 P/Share
|
|
Oct 29
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Bona fide gift
|
Indirect |
3,822
-10.99%
|
-
|
|
Oct 28
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
64,400
-0.11%
|
$6,053,600
$94.0 P/Share
|
|
Oct 24
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
31,750
-0.06%
|
-
|
|
Oct 23
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
18,595
-0.03%
|
-
|
|
Oct 02
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-1.56%
|
$2,208,000
$92.55 P/Share
|
|
Oct 01
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
3,205
-4.31%
|
$298,065
$93.39 P/Share
|
|
Sep 23
2025
|
Stephen A Ellis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,105
+24.02%
|
$58,940
$28.55 P/Share
|
|
Sep 04
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-1.54%
|
$2,304,000
$96.64 P/Share
|
|
Sep 02
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
3,205
-7.78%
|
$304,475
$95.2 P/Share
|
|
Aug 28
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
6,144
-34.01%
|
$589,824
$96.81 P/Share
|
|
Aug 28
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
6,144
+12.42%
|
$282,624
$46.39 P/Share
|
|
Aug 27
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
3,296
-21.66%
|
$319,712
$97.18 P/Share
|
|
Aug 27
2025
|
Peter J. Morgan Iii General Counsel |
SELL
Open market or private sale
|
Direct |
50,016
-100.0%
|
$4,851,552
$97.0 P/Share
|
|
Aug 27
2025
|
Peter J. Morgan Iii General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
50,016
+49.44%
|
$2,750,880
$55.24 P/Share
|
|
Aug 27
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
136,500
-0.24%
|
$13,240,500
$97.04 P/Share
|
|
Aug 26
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
136,500
-0.24%
|
$13,104,000
$96.67 P/Share
|
|
Aug 25
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
13,542
-0.92%
|
$1,300,032
$96.06 P/Share
|
|
Aug 08
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
133,153
-0.12%
|
$12,782,688
$96.72 P/Share
|
|
Aug 07
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
22,721
-0.04%
|
$2,181,216
$96.02 P/Share
|
|
Aug 07
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-0.75%
|
$2,304,000
$96.95 P/Share
|
|
Aug 01
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
3,290
-7.4%
|
$315,840
$96.06 P/Share
|
|
Jul 29
2025
|
Walter W Bettinger Co-Chairman |
SELL
Open market or private sale
|
Indirect |
173,876
-22.74%
|
$17,039,848
$98.84 P/Share
|
|
Jul 29
2025
|
Richard A Wurster President & CEO |
SELL
Open market or private sale
|
Direct |
20,500
-11.54%
|
$2,029,500
$99.16 P/Share
|
|
Jul 29
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
24,096
-29.0%
|
$2,337,312
$97.91 P/Share
|
|
Jul 29
2025
|
Nigel J Murtagh Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,096
+22.48%
|
$987,936
$41.98 P/Share
|
|
Jul 29
2025
|
Joan Dea Director |
SELL
Bona fide gift
|
Direct |
513
-1.82%
|
-
|
|
Jul 03
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-1.48%
|
$2,184,000
$91.59 P/Share
|
|
Jul 01
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Payment of exercise price or tax liability
|
Direct |
1,035
-2.33%
|
$93,150
$90.74 P/Share
|
|
Jul 01
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
3,290
-8.4%
|
$296,100
$90.95 P/Share
|
|
Jun 24
2025
|
Stephen A Ellis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,853
+21.77%
|
$61,149
$33.12 P/Share
|
|
Jun 18
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
20,872
-26.13%
|
$1,878,480
$90.01 P/Share
|
|
Jun 18
2025
|
Nigel J Murtagh Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,872
+20.72%
|
$876,624
$42.99 P/Share
|
|
Jun 18
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
10,129
-20.55%
|
$911,610
$90.01 P/Share
|
|
Jun 18
2025
|
Paul V Woolway MD, Chief Banking Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,129
+23.08%
|
$465,934
$46.81 P/Share
|
|
Jun 05
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-1.46%
|
$2,088,000
$87.25 P/Share
|
|
Jun 03
2025
|
Michael D Verdeschi CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,888
-9.84%
|
$512,256
$87.54 P/Share
|
|
Jun 02
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
3,290
-7.75%
|
$286,230
$87.68 P/Share
|